MicroRNA‐351 eases insulin resistance and liver gluconeogenesis via the PI3K/AKT pathway by inhibiting FLOT2 in mice of gestational diabetes mellitus

Gestational diabetes mellitus (GDM) is known as different degree glucose intolerance that is initially identified during pregnancy. MicroRNAs (miRs) may be a potential candidate for treatment of GDM. Herein, we suggested that miR‐351 could be an inhibitor in the progression of GDM via the phosphoino...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shu‐Hong, Liu, Xiao‐Nan, Peng, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714143/
https://www.ncbi.nlm.nih.gov/pubmed/31287224
http://dx.doi.org/10.1111/jcmm.14079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714143/
https://www.ncbi.nlm.nih.gov/pubmed/31287224
http://dx.doi.org/10.1111/jcmm.14079

Ejemplares similares